StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)

Close on Nov 17, 2026Market cap $33.80MP/E –Yield –

Alterity Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Alterity Therapeutics's price to sales ratio was 73.6× on Aug 30, 2019, against 193.9× a year earlier. Over the last 3 years it ranged from 64.9× to 367.7×, with a median of 183.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Aug 30, 201973.6×−6.7
2018Dec 31, 201880.4×−188.0
2017Dec 29, 2017268.3×+127.7
2016Dec 30, 2016140.6×–

More Alterity Therapeutics figures

See a number that looks wrong?